Tyco downsizing
This article was originally published in The Gray Sheet
Executive Summary
Diversified firm's plan to exit over 50 unidentified business units generating $2.1 bil. in sales - including at least some parts of Tyco Healthcare - will save an estimated $230 mil. by 2005, firm predicts. The restructuring program includes consolidating 219 non-healthcare facilities and cutting 7,200 employees, resulting in fiscal 2004 charges of approximately $400 mil. Fiscal fourth quarter 2003 (ended Sept. 30) results announced Nov. 4 included roughly flat revenues of $9.5 bil. and healthcare sales of $2.2 bil. (up 4.6%). The firm foreshadowed the paring of non-core businesses with the divestiture of its Surgical Dynamics spinal unit in June 2002 (1"The Gray Sheet" June 10, 2002, p. 3)...
You may also be interested in...
Tyco Divestiture Gives Stryker Opportunity To Tie OP-1 With Ray Spinal Cage
Access to Surgical Dynamics' Ray TFC and TFC Unite threaded fusion cages will allow Stryker to compete more effectively with Medtronic in the spinal fusion market, pending FDA approval of bone growth factor products
Scrip M&A Podcast: Which Companies Could Be Acquired Next?
The editorial team from Scrip discusses the M&A potential of various emerging biopharmas, such as Viking, Verona, Altimmune, Xenon and Crinetics.
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.